Colorectal cancer-specific methylation biomarkers for diagnosing colorectal cancer
US11821045B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 13, 2021 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Jun 23, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/154
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided is a colorectal cancer-specific methylation biomarker for diagnosing colorectal cancer. Since a gene marker according to an embodiment exhibits a specific methylation pattern in colorectal cancer tissue, it can be usefully used as a methylation marker for diagnosing colorectal cancer, thereby increasing the cure rate of colorectal cancer by early diagnosis and treatment of colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.